This study has revealed an interesting potentiation of L-CAV in combination with chemotherapeutic drugs, specific DNA-targeting drugs in L-ARG auxotrophic and non-auxotrophic cancer cell lines. This evidence concerns the gene ARHGEF12 and cancer.